incontinence 发表于 2025-3-28 14:39:45

Book 2017iveness of treatment for chronic myeloid leukemia and acute promyelocytic leukemia has been dramatically improved in recent years. This improvement has been made possible with the development of molecular targeted agents such as bcr-abl tyrosine kinase inhibitors and all-trans retinoic acid. The ant

paradigm 发表于 2025-3-28 19:43:14

http://reply.papertrans.cn/23/2250/224970/224970_42.png

cogitate 发表于 2025-3-29 01:46:04

http://image.papertrans.cn/c/image/224970.jpg

描绘 发表于 2025-3-29 04:07:46

https://doi.org/10.1007/978-981-10-3332-2Acute promyelocytic leukemia; Chronic myeloid leukemia; Molecular targeted agent; antimetabolite analog

neutralize 发表于 2025-3-29 09:57:06

http://reply.papertrans.cn/23/2250/224970/224970_45.png

勤劳 发表于 2025-3-29 15:28:02

http://reply.papertrans.cn/23/2250/224970/224970_46.png

包庇 发表于 2025-3-29 18:26:52

An Overview,There has been remarkable progress in chemotherapy for leukemia and related diseases, including promising studies that are still in progress. The contents consist of three parts:.In this chapter, an overview of these drugs presented in this book is briefly described.

Hirsutism 发表于 2025-3-29 21:10:42

http://reply.papertrans.cn/23/2250/224970/224970_48.png

inundate 发表于 2025-3-30 02:06:28

http://reply.papertrans.cn/23/2250/224970/224970_49.png

震惊 发表于 2025-3-30 05:16:06

http://reply.papertrans.cn/23/2250/224970/224970_50.png
页: 1 2 3 4 [5] 6
查看完整版本: Titlebook: Chemotherapy for Leukemia; Novel Drugs and Trea Takanori Ueda Book 2017 Springer Nature Singapore Pte Ltd. 2017 Acute promyelocytic leukemi